"Permissive AKI" with treatment of heart failure
- PMID: 31648696
- DOI: 10.1016/j.kint.2019.07.003
"Permissive AKI" with treatment of heart failure
Abstract
Renin-angiotensin-aldosterone system inhibitors have proven clinical benefit in management of patients with heart failure with reduced ejection fraction. However, there are no guidelines to manage decline in kidney function that occurs with initiation and titration of renin-angiotensin-aldosterone system agents during management of heart failure. We discuss the complex interplay of kidney function and heart failure in the presence of renin-angiotensin-aldosterone system agents and suggest a clinical algorithm for management of acute decline in kidney function.
Copyright © 2019 International Society of Nephrology. Published by Elsevier Inc. All rights reserved.
Comment on
-
Acute declines in estimated glomerular filtration rate on enalapril and mortality and cardiovascular outcomes in patients with heart failure with reduced ejection fraction.Kidney Int. 2019 Nov;96(5):1185-1194. doi: 10.1016/j.kint.2019.05.019. Epub 2019 Jun 11. Kidney Int. 2019. PMID: 31420191 Free PMC article. Clinical Trial.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
